The effects of testosterone on intestinal ischemia/reperfusion in rats

Journal of Investigative Surgery

Volumn 24, Issue 6, 2011, Pages 283-291

  Albayrak, Yavuz ^a   Halici, Zekai ^b   Odabasoglu, Fehmi ^c   Unal, Deniz ^b   Keles, Osman Nuri ^b   Malkoc, Ismail ^b   Oral, Akgun ^b   Yayla, Muhammed ^b   Aydin, Ozlem ^c   Unal, Bunyami ^b  

^a Education and Research Hospital ^*  (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Histopathology; Intestine; Ischemia reperfusion; Orchiectomy; Oxidative stress; Rat; Testosterone

Indexed keywords

GLUTATHIONE; LIPID; MYELOPEROXIDASE; PROTEIN; SUPEROXIDE DISMUTASE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HORMONE ACTION; INTESTINE CELL; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA; LIPID PEROXIDATION; MALE; NONHUMAN; ORCHIECTOMY; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURGICAL TECHNIQUE; TESTOSTERONE BLOOD LEVEL;

ANIMALS; INTESTINAL DISEASES; INTESTINES; MALE; ORCHIECTOMY; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; REPERFUSION INJURY; TESTOSTERONE;

EID: 80455158189     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2011.591894     Document Type: Article

References (39)

1. Yasuhara H. Acute mesenteric ischemia: The challenge of gastroenterology. Surg Today 2005;35:185-195.
2. Guven A, Tunc T, Topal T, et al. Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine. Surg Today. 2008;38:1029-1035.
3. Tunc T, Uysal B, Atabek C, et al. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res. 2009;155:210-216.
4. Villa X, Kuluz JW, Schleien CL, et al. Epidermal growth factor reduces ischemia-reperfusion injury in rat small intestine. Crit Care Med. 2002;30:1576-1580.
5. Haglund U. Gut ischaemia. Gut. 1994;35:73-76.
6. Souza DG, Coutinho SF, Silveira MR, et al. Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. Eur J Pharmacol. 2000;403:121-128.
7. Sakrak O, Kerem M, Bedirli A, et al. Ergothioneine modulates proinflammatory cytokines and heat shock protein 70 in mesenteric ischemia and reperfusion injury. J Surg Res. 2008;144:36-42.
8. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94:1133.
9. Erdogan H, Fadillioglu E, Yagmurca M, et al. Protein oxidation and lipid peroxidation after renal ischemiareperfusion injury: Protective effects of erdosteine and Nacetylcysteine. Urol Res. 2006;34:41.
10. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002;282:227-241.
11. Guneli E, Cavdar Z, Islekel H, et al. Erythropoietin protects the intestine against ischemia/reperfusion injury in rats. Mol Med. 2007;13:509-517.
12. Mallick IH, Yang W, Winslet WC, et al. Ischemia-Reperfusion Injury of the Intestine and Protective Strategies Against Injury. Dig. Dis. Sci. 2004;49:1359-1377.
13. Wang M, Tsai BM, Kher A, et al. Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2005;288:221-226.
14. Akçora B, Altuǧ E, Kontaş T, et al. Orchiectomy or testosterone receptor blockade reduces intestinal mucosal damage caused by ischemia-reperfusion insult. Pediatr Surg Int. 2008;24:337-341.
15. Kim J, Kil IS, Seok YM, et al. Orchiectomy attenuates postischemic oxidative stress and ischemia/reperfusion injury in mice: A role for manganese superoxide dismutase. J Biol Chem. 2006;281:20349-20356.
16. Megison SM, Horton JW, Chao H, et al. A new model for intestinal ischemia in the rat. J Surg Res. 1990;49:168.
17. Chiu CJ,McArdle AH, Brown R, et al. Intestinalmucosal lesion in low-flow states: I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101:478.
18. Sun Y,Oberley LW, Li YA. Simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
19. Ohkawa H, Ohishi N, Yagi K. Assayforlipidperoxides in animaltissuesbythiobarbituricacidreaction. Anal Biochem. 1979;95:351-358.
20. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192-205.
21. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci. 1994;307:284-292.
22. Kettle AJ, Winterbourn CC. Myeloperoxidase: A key regulator of neutrophil oxidant production. Redox Rep. 1997;3:3-15.
23. Marin DP, Bolin AP, dos Santos Rde C, et al. Testosterone suppresses oxidative stress in human neutrophils. Cell Biochem Funct. 2010;28:394-402.
24. Bennett MJ, Albert, RH, Jez, JM, et al. Steroid recognition and regulation of hormone action: Crystal structure of testosterone and NADPş bound to 3 alphahydroxysteroid/dihydrodiol dehydrogenase. Structure. 1997;5:799-812.
25. Kettle AJ, Winterbourn CC. Myeloperoxidase: A key regulator of neutrophil oxidant production. Redox Rep. 1997;3:3-15.
26. Yildiz Y, Serter M, Ek RO, et al. Protective effects of caffeic acid phenethyl ester on intestinal ischemia-reperfusion injury. Dig Dis Sci. 2009;54:738-744.
27. Iwasaki Y, Asai M, Yoshida M, et al. Dehydroepiandrosterone-sulfate inhibits nuclear factor- B-dependent transcription in hepatocytes possibly through antioxidant effect. J Clin Endocrinol Metab. 2004;89: 3449-3454.
28. vanVollenhoven RF. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother. 2002;3:23-31.
29. Straub RH, Scholmerich J, Zietz B. Replacement therapy with DHEAplus corticosteroids in patientswith chronic inflammatory diseases-substitutes of adrenal and sex hormones. Z Rheumatol. 2000:59(Suppl. 2):II/108-118.
30. Szabo A, Vollmar B, Boros M, et al. Gender differences in ischemia-reperfusion-induced microcirculatory and epithelial dysfunctions in the small intestine. Life Sci. 2006;78:3058-3065.
31. Tep-areenan P, Kendall DA, Randall MD. Testosteroneinduced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol. 2002;135:735-740.
32. Kuhar P, Lunder M, Drevensek G. The role of gender and sex hormones in ischemic-reperfusion injury in isolated rat hearts. Eur J Pharmacol. 2007;561:151-159.
33. Jones RD, English KM, Jones TH, et al. Testosterone induced coronary vasodilatation occurs via a non-genomic mechanism: Evidence of a direct calcium antagonism action. Clin Sci. Lond. 2004;107:149-158.
34. Yildiz, O., Seyrek, M., Gul, H., et al. Testosterone relaxes human internalmammary artery in vitro. J Cardiovasc Pharmacol. 2005;45:580-585.
35. Yue P, Chatterjee K, Beale C, et al. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91:1154-1160.
36. Tsang S, Wu S, Liu J, et al. Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha1-adrenoceptor stimulation. Br J Pharmacol. 2008;153:693-709.
37. Golden KL, Marsh JD, Jiang Y. Testosterone regulates mRNA levels of calcium regulatory proteins in cardiac myocytes. Horm Metab Res. 2004;36:197-202.
38. Brechet S, Plaisancíe P, Dumoulin V, et al. Involvement of beta1- and beta2- but not beta3-adrenoceptor activation in adrenergic PYY secretion from the isolated colon. J Endocrinol. 2001;168:177-183.
39. Roberts SJ, Papaioannou M, Evans BA, et al. Characterization of beta-adrenoceptor mediated smooth muscle relaxation and the detection of mRNA for beta-1, beta-2 and beta-3 adrenoceptors in rat ileum. Br J Pharmacol. 1999;127:949-961.